Author pages are created from data sourced from our academic publisher partnerships and public sources.
Share This Author
Efficacy and safety of RPL554, a dual PDE3 and PDE4 inhibitor, in healthy volunteers and in patients with asthma or chronic obstructive pulmonary disease: findings from four clinical trials.
- L. Franciosi, Z. Diamant, +12 authors C. Page
- The Lancet. Respiratory medicine
- 1 November 2013
Overall, RPL554 was well tolerated, and adverse events were generally mild and of equal frequency between placebo and active treatment groups. Expand
Allergic rhinitis and its pharmacology.
This review summarizes the current knowledge of allergic rhinitis, its prevalence, pathophysiology and experimental and clinical treatments and special emphasis is placed upon potential new treatments. Expand
Markers of exacerbation severity in chronic obstructive pulmonary disease
Arterial carbon dioxide and breathing rate varied in a consistent manner with exacerbation severity and patient setting, and many other measures showed weak correlations that should be further explored in future longitudinal studies or assessed using suggested mathematical modelling techniques. Expand
Markers of disease severity in chronic obstructive pulmonary disease.
- L. Franciosi, C. Page, +5 authors O. Della Pasqua
- Pulmonary pharmacology & therapeutics
- 1 June 2006
Little separation between disease stages is observed for many measures used in COPD diagnosis and clinical trials, demonstrating the poor sensitivity of such endpoints to define a patient's clinical status and to quantify treatment effect. Expand
Markers of exacerbation severity in chronic obstructive pulmonary disease.
Arterial carbon dioxide tension and breathing rate varied in a consistent manner with exacerbation severity and patient setting, and many other measures showed weak correlations that should be further explored in future longitudinal studies or assessed using suggested mathematical modelling techniques. Expand
A comprehensive model of allergic rhinitis in guinea pigs.
- M. Al Suleimani, D. Ying, M. Walker
- Journal of pharmacological and toxicological…
- 1 March 2007
The model reported in this study can be used to reflect the effectiveness of drugs currently used to treat allergic Rhinitis and to investigate new potential drugs for the treatment of allergic rhinitis. Expand
Drugs and the Nervous System (Peripheral and Central)
Actions of prostaglandins I2 and E2 on coronary occlusion-induced arrhythmias in the rat.
Physicochemical determinants for drug induced blockade of HERG potassium channels: effect of charge and charge shielding.
- A. Zolotoy, Bertrand Plouvier, Gregory B Beatch, E. Hayes, R. Wall, M. Walker
- Medicine, Biology
- Current medicinal chemistry. Cardiovascular and…
- 30 September 2003
The introduction of a hydroxy group at position 3 relative to a tertiary ammonium charged center, or the introduction of hydroxy, alkoxy or amino groups at position 2 relative to the nitrogen center of an aromatic system, should provide easy access of a water molecule to the proton, thereby facilitating deprotonation and thus leading to a moderate or weak HERG/I(Kr) blockade and a reduced risk of TdP. Expand